CSIRO and Oventus first worked together to develop the O2Vent? device in 2013. The Oventus additive manufacturing facility at Clayton uses 3D printed titanium technology to produce their customised product that treats obstructive sleep apnoea (OSA) and snoring. The successful collaboration between the two organisations has resulted in innovation in computational modelling, and 3D design and production processes.
Click below to view the video on this innovative partnership and development of the O2Vent T device.
Leave a Reply